DiaMedica Therapeutics Inc.
DMAC
$5.42
-$0.19-3.39%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 9.79M | 9.78M | 9.22M | 8.52M | 8.05M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 36.74M | 34.40M | 33.60M | 31.45M | 29.08M |
| Operating Income | -36.74M | -34.40M | -33.60M | -31.45M | -29.08M |
| Income Before Tax | -35.07M | -32.74M | -31.90M | -29.55M | -26.97M |
| Income Tax Expenses | 29.00K | 28.00K | 27.00K | 28.00K | 29.00K |
| Earnings from Continuing Operations | -35.10 | -32.77 | -31.93 | -29.58 | -27.00 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -35.10M | -32.77M | -31.93M | -29.58M | -27.00M |
| EBIT | -36.74M | -34.40M | -33.60M | -31.45M | -29.08M |
| EBITDA | -36.69M | -34.35M | -33.56M | -31.42M | -29.04M |
| EPS Basic | -0.71 | -0.70 | -0.72 | -0.69 | -0.65 |
| Normalized Basic EPS | -0.44 | -0.44 | -0.45 | -0.43 | -0.40 |
| EPS Diluted | -0.71 | -0.70 | -0.72 | -0.69 | -0.65 |
| Normalized Diluted EPS | -0.44 | -0.44 | -0.45 | -0.43 | -0.40 |
| Average Basic Shares Outstanding | 198.80M | 187.85M | 178.24M | 171.36M | 166.47M |
| Average Diluted Shares Outstanding | 198.80M | 187.85M | 178.24M | 171.36M | 166.47M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |